104th Annual Meeting of the American Psychopathological Association

March 6-8, 2014 Grand Hyatt New York

Hieronymus Bosch - Cure of Folly c.1494

Pursuing Personalized Treatment for Mental Illness

There are numerous evidenced based treatments for psychiatric disorders, using pharmacological and psychotherapeutic approaches. Predicting which of these therapies will work for any given individual remains as much an art as a science, resulting in therapeutic delays, needless costs, and human suffering. A new era of personalized medicine tailored to the patient's unique biomarkers to specify treatment choices is beginning to emerge throughout medicine and in psychiatry.

The 2014 APPA annual meeting brings together experts to describe the most promising biomarkers, which may form the basis for future personalized treatment. Scientists who are carrying out therapeutic trials testing biomarkers alone or in combination to treat individuals with depression, anxiety disorders, schizophrenia or addiction, will also describe their most recent and salient findings.

Jeffrey A. Lieberman, PhD, President 2014

Myrna M. Weissman, PhD and Anissa A. Abi-Dargham, MD, Program Co-Chairs

Download Full Program

What are Biomarkers?
Thomas Insel
Nora D. Volkow
Preben Bo Mortensen
David J. Kupfer
Geoffrey M. Reed
Bruce N. Cuthbert
Husseini K. Manji
Chair: Myrna M. Weissman

Ed Bullmore
Anissa A. Abi-Dargham
Patrick F. Sullivan
Alan S. Brown
Kristen J. Brennand
György Buzsáki
Chairs: J. Raymond DePaulo, Jr. and Robert M.A. Hirschfeld

Promising Biomarkers
Eric J. Nestler
Joseph Piven
Maria Karayiorgou
George F. Koob
Robert L. Klitzman
Helen S. Mayberg
Ramin V. Parsey
Steven M. Paul
Charles R. Marmar
Chairs: Mary Jeanne Kreek and Shelli Avenevoli